Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colorectal ACF Screening, Regression And Prevention In High Risk Participants
NCT00062023Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2003
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sulindac in colorectal cancer (CRC), sponsored by University of Texas MD Anderson Cancer Center. Started Jun 2003; status: terminated.
02
Drugs
sulindac
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00062023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00062023.